IBCN 2018: Bladder Cancer and Therapy from an Immunologist's Perspective
In summary, the tumor environment has unique differences according to sex. These have important implications in study design and targeted therapies. Moreover, we need to see immunology in all stages of bladder cancer which have different immune response and microenvironments.
Presented by: Molly Ingersoll, Ph.D., Department of Immunology, Institut Pasteur, Paris, France
Written by: Stephen B. Williams, M.D., Associate Professor, Division of Urology, The University of Texas Medical Branch, Galveston, TX. and Ashish M. Kamat, M.D. Professor, Department of Urology, Division of Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX at the 16th Annual Meeting of the International Bladder Cancer Network (IBCN) October 11-13, 2018 - the Inntel Hotels Rotterdam Centre, Rotterdam, The Netherlands